OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GRFS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Grifols SA (GRFS) Earnings Date & Reports

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GRFS is expected to report earnings to rise 3.77% to 23 cents per share on November 06

Q3'25

Est.

$0.23

Q2'25

Est.

$0.22

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.04

The last earnings report on July 29 showed earnings per share of 22 cents, meeting the estimate of 22 cents. With 821.80K shares outstanding, the current market capitalization sits at 8.92B.

View a ticker or compare two or three

Compare

GRFS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GRFS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRFS showed earnings on July 29, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a manufacturer of plasma-derived biological medicines

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

Avinguda de la Generalitat, 152

Phone

+34 935712200

Employees

23744

Web

https://www.grifols.com